INJ pays for transactions on the network, which the network itself advertises as costing less than a cent each. It is also staked by validators, the computers that confirm transactions and keep the network running, and it is used to vote on changes to how Injective works.

What happens to the money Injective earns from its own exchange module is unusual, and it is the subject of the next section.

Over the trailing year, Injective's exchange module brought in $4,475,675 in fees. Every one of those dollars counts as revenue, and every one of those dollars is destroyed: burned in a recurring on-chain auction, rather than paid to a company, a foundation, or anyone else. There is no third category here, no portion quietly routed to a treasury. Fees, revenue, and what reaches holders are, on Injective, the same number.

When an outside application plugs into Injective's shared exchange infrastructure rather than building its own, the split changes slightly: 60% of the revenue that application generates still goes to the burn, and the remaining 40% stays with the application itself, to support running its own service. That 40% is not kept by Injective or by INJ holders; it is the cost of letting someone else's product use shared infrastructure instead of building their own.

Injective's fee history goes back more than five years, to July 2021, one of the longer records this framework has measured. Across that whole history, the network has earned $38,918,960 in fees. Only about 11.5% of that total arrived in the most recent twelve months.

The shape behind that number is a genuine rise and fall, twice over. Fees spiked hard in the network's first months, reaching a peak of $2,309,489 in a single month in December 2021, then fell back sharply and stayed low through most of 2022 and 2023. A second, slower climb followed through 2024, peaking near $1.9 million in a single month, before declining again through 2025 and into 2026, where recent months have run well under $300,000. Measured over just the most recent three months, the annualised pace is $3,169,161.17, about 29% below the trailing-year total, a real and recent slowdown rather than a rounding difference.

Beyond the network itself, a separate set of applications, mostly trading and lending platforms, runs on top of Injective and holds user funds. The total value held inside those applications, a common measure of how much genuine activity a network's ecosystem is getting, tells its own story.

That total peaked at $71,334,493 in June 2024. It then fell so far that, for roughly six weeks across June and August 2026, it dropped below $9,036,343, the very first total-value figure ever recorded for this chain, back in November 2022. A network's current activity falling below its own starting point, more than three years after it began being measured, is a genuinely rare finding. That low has since passed: by the final days of August 2026, the total had climbed back above that historic floor, to a little over $10.5 million. It remains far below the 2024 peak.

Two things are both true. The collapse was real, sustained for weeks, and severe enough to fall below where this chain's measured history began. It was not, as of the most recent data available, a permanent floor.

Injective's market value, the price of every INJ in existence multiplied together, is $697,237,554. Divide that by the annualised fee run-rate from the most recent three months and Injective trades at roughly 220 times its current yearly fee income.

For comparison, a wireless network project this framework has used as its example of an extreme, speculative valuation traded at roughly 87,000 times its own fees. Injective's multiple is more than two orders of magnitude smaller. This is not among the very best multiples this framework has measured, but it is unremarkable in a good way: nowhere near the range that signals a price disconnected from activity.

Injective's maximum supply is fixed at 99,644,000 INJ, and every token that will ever exist under that cap already has an assigned purpose. There are no tokens set aside for ongoing incentive rewards. A full schedule of 25 token-release events has completed entirely, with nothing left pending and nothing left undetermined.

Of the total supply, 46.2% is allocated to the network's own ecosystem and community funds (36.1% and 10% respectively), already assigned rather than awaiting a future decision. Another 22.7% went to private and seed-round investors before INJ was publicly tradable. 22.1% belongs to the team and advisors behind the project (20.1% and 2%). The remaining 9% was distributed through a public token sale. This allocation is frozen: the current split and the final split are the same numbers, and nothing can shift between categories from here.

A small number of validators, the computers that confirm transactions and keep Injective running, hold outsized voting power. According to a 2023 industry review, four validators together held more than a third of all voting power on the network, enough on their own to pass or block changes without needing anyone else's agreement. That review is now roughly three years old, so it describes a documented past state rather than necessarily today's exact numbers, but no more recent figure is available.

One current, verifiable fact adds to the picture: Injective's own Foundation runs one of the network's validators at a 100% commission rate. Anyone who delegates their INJ to that particular validator to help secure the network keeps none of the reward for doing so; all of it goes to the Foundation. A separate validator, run by Google Cloud, is set up the same way. Most other validators on the network charge between 5% and 10%.

A real mitigation effort exists. The Open DeFi Foundation has run a Delegation Program specifically aimed at shifting voting power toward smaller validators, reducing the concentration described above over time.